Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial

JA Udell, DL Bhatt, E Braunwald, MA Cavender… - Diabetes …, 2015 - Am Diabetes Assoc
OBJECTIVE The glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with few treatment options. We investigated the effect of …
被引用次数：216 相关文章

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial.

JA Udell, DL Bhatt, E Braunwald, MA Cavender… - Diabetes …, 2014 - europepmc.org
Objective The glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with few treatment options. We investigated the effect of …

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

JA UDELL, DL BHATT, E BRAUNWALD… - 2015 - observatorio.fm.usp.br
OBJECTIVEThe glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with few treatment options. We investigated the effect of …

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

JA Udell, DL Bhatt, E Braunwald, MA Cavender… - Diabetes Care, 2014 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> OBJECTIVE</jats: title>< jats: p> The glycemic management of
patients with type 2 diabetes mellitus (T2DM) and renal impairment is challenging, with few …

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial

JA Udell, DL Bhatt, E Braunwald, MA Cavender… - 2015 - pubmed.ncbi.nlm.nih.gov
Objective The glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with few treatment options. We investigated the effect of …

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: Observations from the SAVOR-TIMI 53 trial

SAVOR-TIMI 53 Steering Committee … - Diabetes …, 2015 - utsouthwestern.elsevierpure.com
OBJECTIVE The glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with fewtreatment options. We investigated the effect of …
[PDF] academia.edu

[PDF][PDF] Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 …

LA Leiter, I Raz - Diabetes Care, 2015 - academia.edu
OBJECTIVE The glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with few treatment options. We investigated the effect of …

[引用][C] Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 …

JA Udell, DL Bhatt, E Braunwald, MA Cavender… - Diabetes …, 2015 - repositorio.usp.br
ReP USP - Detalhe do registro: Saxagliptin and Cardiovascular Outcomes in Patients With
Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI …

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial.

JA Udell, DL Bhatt, E Braunwald… - Diabetes …, 2015 - search.ebscohost.com
OBJECTIVE The glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with fewtreatment options. We investigated the effect of …

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

JA UDELL, DL BHATT, E BRAUNWALD… - Diabetes …, 2015 - observatorio.fm.usp.br
OBJECTIVEThe glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with few treatment options. We investigated the effect of …